CCL18
C-C motif chemokine 18
Also known as: AMAC-1, CCL18_HUMAN, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55774
- Gene
- CCL18
- Ensembl
- ENSG00000275385
- Chromosome
- 17
- Canonical length
- 89 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for naive T cells, CD4+ and CD8+ T cells and nonactivated lymphocytes, but not for monocytes or granulocytes. This chemokine attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes. It may play a role in both humoral and cell-mediated immunity responses. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
89 residues, UniProt reviewed canonical sequence.
>P55774|CCL18
1 MKGLAAALLV LVCTMALCSC AQVGTNKELC CLVYTSWQIP QKFIVDYSET SPQCPKPGVI
61 LLTKRGRQIC ADPNKKWVQK YISDLKLNALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCL18 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- lung: 47 nTPM
- adipose tissue: 9 nTPM
- small intestine: 8.8 nTPM
- blood vessel: 8.2 nTPM
- lymph node: 6.8 nTPM
- thymus: 5.7 nTPM
Single-cell type
- early spermatids: 9.4 nCPM
- late spermatids: 4.7 nCPM
- macrophages: 4 nCPM
- innate lymphoid cells: 0.7 nCPM
- cdc: 0.6 nCPM
- choroid plexus epithelial cells: 0.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 0.3 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCL18.
Disease | ImmuneIEDB
Conditions an epitope on CCL18 was assayed in.
- berylliosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cell chemotaxis
- cell communication
- cell-cell signaling
- chemokine-mediated signaling pathway
- chemotaxis
- immune response
- inflammatory response
- positive regulation of cell migration
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCL18 as an antibody target. Whether an autoantibody or antibody against CCL18 could matter depends on whether native CCL18 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCL18 is annotated as secreted, so native CCL18 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- It may play a role in both humoral and cell-mediated immunity responses.
Loading the interactive Seroatlas protein explorer...